Revenue Update on Dynatronics Corporation(NASDAQ:DYNT)

Dynatronics Corporation(NASDAQ:DYNT) announced the earnings results for Fiscal Year 2017 and Q2. The results came in during After-Market on Feb 13, 2017. Based on the corporate Earnings and Guidance, many Investment Banking firms balance their portfolio to Sell and Buy Stocks based on their strategy of investing in stocks.Earnings per share were $-0.19.

Dynatronics Corporation (DYNT) made into the market gainers list on Wednesdays trading session with the shares advancing 3.85% or 0.1 points. Due to strong positive momentum, the stock ended at $2.7, which is also near the day’s high of $2.7. The stock began the session at $2.7 and the volume stood at 1,625 shares. The 52-week high of the shares is $3.2107 and the 52 week low is $2.2873. The company has a current market capitalization of $8.2 M and it has 30,36,642 shares in outstanding.

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications including therapy devices medical supplies and soft goods treatment tables and rehabilitation equipment. They are used by physical therapists chiropractors sports medicine practitioners podiatrists physicians and other physical medicine professionals. It markets a line of devices that include electrotherapy ultrasound or a combination of both of these modalities in a single device. The Company’s Dynatron Solaris Plus and Dynatron 25 Series include combination devices that provide electrotherapy and ultrasound therapy treatments to patients. It also distributes a line of iontophoresis electrodes under the brand name of Dynatron Ion electrodes along with other types of iontophoresis electrodes from other manufacturers. It sells products manufactured by others as well as its own product lines.

Add Comment